Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/103098
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sachan, Shubhra | - |
dc.contributor.author | Gonzalez Moya, Celia | - |
dc.contributor.author | Voigt, Bruno | - |
dc.contributor.author | Köhn, Marcel | - |
dc.contributor.author | Balbach, Jochen | - |
dc.date.accessioned | 2023-04-25T07:11:39Z | - |
dc.date.available | 2023-04-25T07:11:39Z | - |
dc.date.issued | 2023 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/105051 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/103098 | - |
dc.description.abstract | The parathyroid hormone (PTH) regulates the calcium and phosphate level in blood after secretion from parathyroid chief cells. The pre- and pro-sequences of precursor preproPTH get cleaved during PTH maturation. In secretory granules, PTH forms functional amyloids. Using thioflavin T fibrillation assays, circular dichroism, NMR spectroscopy, and cellular cAMP activation, we show that the pro-sequence prevents premature fibrillation by impairing primary nucleation because of Coulomb repulsion of positively charged residues. Under seeding or high salt conditions or in the presence of heparin at pH 5.5, proPTH fibril formation is delayed, but the monomer release properties are conserved. ProPTH can still activate in cellulo PTH receptor 1 but with impaired potency. These findings give some perspectives on medical applications of PTH in hormone therapy. | eng |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.subject.ddc | 530 | - |
dc.title | The pro-sequence of parathyroid hormone prevents premature amyloid fibril formation | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | FEBS letters | - |
local.bibliographicCitation.volume | 597 | - |
local.bibliographicCitation.issue | 7 | - |
local.bibliographicCitation.pagestart | 995 | - |
local.bibliographicCitation.pageend | 1006 | - |
local.bibliographicCitation.publishername | Wiley | - |
local.bibliographicCitation.publisherplace | Chichester | - |
local.bibliographicCitation.doi | 10.1002/1873-3468.14587 | - |
local.subject.keywords | functional amyloids; GPCR receptor activation; parathyroid hormone; pro-sequence; PTH1 receptor; ThT fibrillation | - |
local.openaccess | true | - |
dc.identifier.ppn | 1843480956 | - |
local.bibliographicCitation.year | 2023 | - |
cbs.sru.importDate | 2023-04-25T07:11:16Z | - |
local.bibliographicCitation | Enthalten in FEBS letters - Chichester : Wiley, 1968 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FEBS Letters - 2023 - Sachan - The pro‐sequence of parathyroid hormone prevents premature amyloid fibril formation.pdf | 2.14 MB | Adobe PDF | View/Open |